Top Stories

With Actos ads, Takeda looks to distance drug from Avandia

November 16, 2007

Days after FDA ordered a second black-box warning for GlaxoSmithKline's controversial diabetes drug Avandia, Takeda is looking to capitalize on the news with full-page print ads for Actos.
 

Ascend shutters mags for lack of pharma ads

November 20, 2007

Ascend Media is shedding its titles dependent on pharma ad revenue.
 

Celgene to purchase Pharmion for $2.9 billion

November 19, 2007

Biotech company Celgene announced it has agreed to acquire blood cancer treatment maker Pharmion for $2.9 billion in cash and stock.
 

In Other News

Sales of Novartis' Prexige suspended in UK, Germany and Austria

November 19, 2007

The UK, Germany and Austria on Monday suspended sales and marketing of Novartis' COX-2 class painkiller Prexige due to fears the drug may cause liver damage in some patients.
 

Pfizer adds R&D depth with $164 million Coley acquisition

November 16, 2007

Pfizer today said it will acquire Wellesley, MA-based Coley Pharmaceutical for $164 million to add depth to its vaccine research and boost development of drug candidates to fight cancers, allergy and asthma disorders and autoimmune diseases.
 

People Moves

November 20, 2007

CellCyte Genetics Corporation has appointed Tony Colasin director of business development.
 

Product news

November 20, 2007

Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals announced that the FDA has approved a supplemental New Drug Application for Nexavar (sorafenib) tablets for the treatment of patients with unresectable hepatocellular carcinoma, or liver cancer.
 

Company news

November 20, 2007

Schering-Plough Corporation announced that it has received antitrust clearance from the Federal Trade Commission regarding its planned acquisition of Organon BioSciences from Akzo Nobel as announced March 12.
 

Account wins

November 20, 2007

Pacific Communications has been chosen as the agency of record for the partnership between Allergan and IVIVI Technologies, a leader in noninvasive electrotherapeutic technologies based in Northvale, NJ.
 

Webcast

5 BIG REASONS for taking pharmaceutical marketing online

Available on demand
Many pharmaceutical marketers are still unsure about entering the digital landscape and even less certain of what to do when they get there. Interactive marketing experts from Google and pharmaceutical companies discuss why marketers should take the plunge and how it could positively impact their businesses. Click here for more information and to register for this webcast. 

Sponsored by Google.

 





Advertise
For details on how to advertise in MM&M News Brief, please email Doreen Gates

Unsubscribe
To unsubscribe from the MM&M News Brief click here.
To manage your entire MM&M profile login to your account.

You are subscribed as: %%EMAIL%%

To contact Haymarket Media for general questions or unsubscribe problems, please reply to this email.

All MM&M newsletters are sent from the domain "email.mmm-online.com". When configuring e-mail or spam
filter rules, please use this domain name.

Medical Marketing & Media Magazine
114 W. 26th Street 4th Floor
New York N.Y. 10001
Phone: (646) 638-6000
Fax: (646) 638-6150
http://www.mmm-online.com/

© 2013 Haymarket Media Inc.